Mitsui USA and PurThread Enter into Distribution Agreement for PurThread's Technology in Japan

Research Triangle Park, N.C –Tuesday, February 27, 2018 – Mitsui & Co. (U.S.A.), Inc. (“Mitsui USA”) and PurThread Technologies, Inc. (“PurThread”) have entered into a distributorship agreement for Mitsui USA to bring PurThread’s patented permanent antimicrobial fibers and yarns to textiles and soft goods across Mitsui & Co.’s  vast production and distribution networks in Japan.

Amidst growing global health concerns, consumers and businesses alike are seeking solutions to reduce their exposure to pathogens that can cause odor and potential illness.  Developed with manufacturers and product designers in mind, PurThread’s innovative fibers and yarns embed pure, natural silver salts to enhance its partners’ products with unsurpassed antimicrobial capability, durability, and freshness without any special handling requirements.  Mitsui’s commitment to the development and market introduction of state of the art technologies in functional textiles creates a strong foundation from which its collaboration with PurThread is built.

“We are extremely pleased to have entered into an agreement with such a highly esteemed global company, whose broad interests span across many sectors where PurThread offers significant benefits.  Sectors such as healthcare, apparel and home goods are all areas where PurThread’s proven technology provides permanent antimicrobial fabric protection,” said Lisa Grimes, President & CEO of PurThread Technologies. “We highly respect Mitsui & Co. for the diligence, research, and testing they have invested which has led to this agreement, and we look forward to working together to bring superior antimicrobial protection to every sector in Japan.”

Yasunori Kondo, General Manager of Mitsui USA’s Lifestyle Business Department, said: “We are delighted to be collaborating with PurThread on the development and marketing of products using their advanced antimicrobial technology in the Japanese market.  With Mitsui’s extensive network in the high functional textile industry, we are confident our synergies will have a great impact.”

About PurThread

PurThread Technologies, Inc. protects fabrics by embedding EPA-registered silver salts into yarns, making them permanently antimicrobial. PurThread yarns protect fabrics from the effects of microbial contamination and reduce odor-causing bacteria, mold, mildew and fungus – for the life of the product. A wide range of consumer, industrial and healthcare textiles benefit from incorporating PurThread, including bed linens, scrubs, uniforms, active wear and other apparel. PurThread fibers and yarns are 100% Made in the USA. For more information, visit

About Mitsui USA

With a long history in the United States, Mitsui & Co. (U.S.A.), Inc. (“Mitsui USA”) is a wholly owned subsidiary of Mitsui & Co., Ltd., Tokyo, Japan, one of the most diversified and comprehensive trading, investment, and service enterprises in the world. Mitsui & Co., Ltd. pursues “360° business innovation” that ranges from product sales, worldwide logistics and financing, through to the development of major international infrastructure and other projects. More information about Mitsui USA may be found at


Study Finds 92% of Hospital Privacy Curtains Contaminated with Pathogenic Bacteria Within One Week

For one person in 20, spending the night in a hospital will lead to an infection, according to the Centers for Disease Control and Prevention (CDC). Now, research recently published by the American Journal for Infection Control reveals 92% of hospital privacy curtains were contaminated with potentially dangerous bacteria such as MRSA (methicillin-resistant Staphylococcus aureus) and VRE (vancomycin-resistant enterococcus) within one week of being laundered.

Read More

Copper Surfaces Study Validates PurThread Technologies' Development Efforts to Reduce Bioburden on Soft Surfaces

Researchers at the Medical University of South Carolina, Memorial Sloan Kettering Cancer Center, and Ralph H. Johnson VA Medical Center have presented results of a study, funded by the U.S. Department of Defense, that links a reduction in environmental bioburden with lower rates of hospital acquired infections (HAIs).

Read More

Study Shows Potential Pathogens Cling to Hospital Privacy Curtains; Contamination Occurs Quickly after Laundering

Within a week of being laundered, 92 percent of hospital privacy curtains were contaminated with potentially pathogenic bacteria such as MRSA (methicillin-resistant S. aureus) and VRE (vancomycin-resistant enterococcus), a new study performed at the University of Iowa Hospital in Iowa City, IA reports.

Read More